Ocular Surgery News
One-year results of the CATT showed that there are alternatives to injecting ranibizumab every 4 weeks, but another year of investigation is needed to draw more definitive conclusions, according to Neil M. Bressler, MD, keynote lecturer at the Advanced Retinal Therapy meeting here.